Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Hackensack, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Protalix BioTherapeutics, Inc. has filed 971 SEC EDGAR filings since 13 Aug 1996

SEC filing history

Showing 326-350 of 685 matching filings.

Per page
25
Current page
14
CT ORDER File 001-33357

CT ORDER filing

Filing date
04 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
07 Nov 2018
Reporting date
07 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33357

DEFINITIVE PROXY STATEMENT

Filing date
17 Oct 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-33357

PRELIMINARY PROXY STATEMENT

Filing date
05 Oct 2018
Reporting date
13 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
05 Oct 2018
Reporting date
05 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
21 Sep 2018
Reporting date
21 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Sep 2018
Reporting date
13 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
13 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
13 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
09 Aug 2018
Reporting date
09 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

8-K

Filing date
24 Jul 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
08 Jun 2018
Reporting date
29 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-225526

FORM S-8

Filing date
08 Jun 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
31 May 2018
Reporting date
28 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
24 May 2018
Reporting date
22 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
14 May 2018
Reporting date
13 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33357

FORM 8-K

Filing date
09 May 2018
Reporting date
09 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33357

DEFA14A

Filing date
18 Apr 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .